Federal regulator hauls huge drug middlemen into court over insulin prices
The government’s antitrust watchdog on Friday sued three massive health conglomerates, accusing their drug middlemen of forcing insulin prices to skyrocket since 2012. The Federal Trade Commission claims that the middlemen — known as pharmacy benefit managers,
The Federal Trade Commission says a $48 million settlement should put an end to what it calls "predatory" tactics by the ...
Congresswoman Dina Titus applauds the Federal Trade Commission’s efforts to crack down against Invitation Homes.According to ...
The FTC has taken action against five entities who have manipulated users through schemes based around AI, deceiving and ...
Ohio Attorney General Dave Yost and 11 other Republican attorneys general on Monday filed a brief in federal court in ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
As the youngest head of the Federal Trade Commission in history, Lina Khan has rallied against Big Tech, challenged deceptive ...
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The FTC launches Operation AI Comply to combat deceptive AI practices, targeting companies like DoNotPay and Ascend Ecom for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback